Table 1.
Baseline demographic and clinical characteristics. Values are numbers (percentages) unless stated otherwise
| Characteristic | n-3 LCPUFA (n=368) | Control (n=338) |
|---|---|---|
| Mean (SD) mother’s age at trial entry (years) | 29.6 (5.7) | 29.5 (5.6) |
| Parity zero | 150 (41) | 131 (39) |
| Maternal smoking during pregnancy | 47 (13) | 45 (13) |
| Mother completed secondary education | 232 (63) | 222 (66) |
| Father completed secondary education | 196 (53) | 182 (54) |
| Maternal history of allergic disease: | 257 (70) | 236 (70) |
| Eczema | 92 (25) | 63 (19) |
| Asthma | 156 (42) | 148 (44) |
| Allergic rhinitis | 133 (36) | 121 (36) |
| Paternal history of allergic disease: | 207 (56) | 178 (53) |
| Eczema | 53 (14) | 37 (11) |
| Asthma | 122 (33) | 86 (25) |
| Allergic rhinitis | 108 (29) | 109 (32) |
| Both parents with history of allergic disease | 109 (30) | 97 (29) |
| Infant’s sex male | 169 (46) | 168 (50) |
LCPUFA=long chain polyunsaturated fatty acid.